Clinical Trial Update: Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating single doses of PPM-204 on the heart's electrical pathways has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• PPM-204

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED